Carterra
Salt Lake City
About Carterra
Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $38.1M
- Funding stage: Late Stage Venture
- Last round: Secondary Market (May 2021)
- Website: carterra-bio.com
- Phone: +1 844 642 7635
Industries & Categories
Biotechnology, Developer Platform, Medical
Social Profiles
Canonical: https://fsome.com/organization/carterra-31059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.